Antiviral Drugs
ShareCompartir
Information for Health Care Professionals
The information on this page should be considered current for the 2016-2017 influenza season for clinical practice regarding the use of influenza antiviral medications. Also see the current summary of recommendations available at Influenza Antiviral Medications: Summary for Clinicians and a list of related references at Antiviral Guide References.
Links on this page contain excerpts from Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza – Recommendations of the Advisory Committee on Immunization Practices (ACIP). PDF Version[1 MB, 28 pages]
-
Influenza Antiviral Medications: A Summary for Clinicians
available as PDF[422 KB, 17 pages]- Antiviral Drug Resistance Among Influenza Viruses
- Use of Antivirals
- Antiviral Drugs for Seasonal Influenza
- Dosage
- Adverse Events
- Drug Interactions
- Emergency Use Authorization
- Additional Information Regarding Influenza Virus Infection Control Among Specific Populations
- Recommendations for Obstetric Health Care Providers Related to Use of Antiviral Medications in the Treatment and Prevention of Influenza
- CDC Considerations Related to Investigational Use of Intravenous Zanamivir for 2016-2017 Influenza Season
- References
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza – Recommendations of the Advisory Committee on Immunization Practices (ACIP)
available as PDF[1 MB, 28 pages]
Additional Information for Health Care Professionals
- CDC Expert Commentary on Medscape: 2016-2017 Influenza Antiviral Recommendations
- CDC Expert Commentary on Medscape: High-Risk Patient With Possible Flu? Start Those Antivirals (Video, password required) April 20, 2015
- Why CDC Recommends Influenza Antiviral Drugs March 3, 2015
- Medical Office Telephone Evaluation of Patients with Possible Influenza January 27, 2015
- CDC Health Update Regarding Treatment of Patients with Influenza with Antiviral Medications Distributed via the CDC Health Alert Network, January 9, 2015, 11:00 ET, CDCHAN-00375
- FDA approves Rapivab to treat flu infection December 22, 2014
- CDC Health Advisory Regarding the Potential for Circulation of Drifted Influenza A (H3N2) Viruses. Distributed via the CDC Health Alert Network, December 3, 2014, 16:00 ET (4:00PM ET), CDCHAN-00374
- Have You Heard: CDC Recommendations for Influenza Antiviral Medications Remain Unchanged April 10, 2014
- Clinician Misperceptions Related to Influenza Testing and Treatment January 23, 2014
- Flu Spotlight: CDC Research Confirms Benefits of Flu Antiviral Drugs, Even Beyond 2 Days After Symptoms Start November 22, 2013
- FDA expands Tamiflu’s use to treat children younger than 1 year December 21, 2012
- Have You Heard: CDC Influenza Antiviral Statement February 7, 2012
Information for the Public
- Page last reviewed: November 4, 2016
- Page last updated: January 11, 2017
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs